April 28, 2000
Patent on a Painkiller Could Be Worth Billions to the U. of Rochester
A drug patent awarded to the University of Rochester for a new class of painkillers could generate billions of dollars in royalties for the institution, potentially becoming the most lucrative patent held by a university, officials there have announced.
The patent covers drugs known as Cox-2 inhibitors, or superaspirin. A team of Rochester researchers discovered the chemical mechanisms that made development of the drugs possible.
Within hours of
This is an article for subscribers only. You may access this article by purchasing a:
Digital or Print Subscription
Web Pass
Already have an account? Log In Now.
-
Administration
-
The Chronicle Review
-
Short Subjects
